Age | ||
 Median | 66 years | |
 Range | 40–89 years | |
 | n | % |
Gender | ||
 Male | 12 | 50.0 |
 Female | 12 | 50.0 |
WHO Performance Status | ||
 0 | 14 | 58.3 |
 1 | 8 | 33.3 |
 2 | 2 | 8.3 |
Tumor size | ||
 Tx | 3 | 12.50 |
 T1 | 2 | 8.30 |
 T2 | 5 | 20.80 |
 T3 | 14 | 58.30 |
Lymph node status | ||
 N0 | 24 | 100 |
 N1 | 0 | 0 |
Distant metastases | ||
 M0 | 23 | 95.80 |
 M1 | 1 | 4.20 |